Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet? Akin C, Arock M, Valent P. J Allergy Clin Immunol 2022;149:1912-1918.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Akin C, Arock M, Valent P. Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet? J Allergy Clin Immunol 2022;149:1912-1918.
PMID: 35487307